Table 2.
Values for outcomes and missing data for the entire transgender and gender-diverse youth cohort and controls
| TGDY cases n = 4172 | Controls n = 16 453 | ||||
|---|---|---|---|---|---|
| No. (%) | Median (25th-75th percentile) | No. (%) | Median (25th-75th percentile) | P | |
| Systolic BP, mm Hg | 1701 (40.8) | 116 (108-124) | 6026 (36.6) | 114 (106-121) | < .0001 |
| Diastolic BP, mm Hg | 1701 (40.8) | 67 (62-73) | 6026 (36.6) | 66 (60-72) | < .0001 |
| BMI | 3829 (91.8) | 23 (20-28) | 14 633 (88.9) | 22 (19-26) | < .0001 |
| BMI, % | 3829 (91.8) | 77 (41-95) | 14 633 (88.9) | 69 (39-90) | < .0001 |
| ALT, IU/L | 1627 (39.0) | 24 (17-31) | 3940 (23.9) | 24 (16-32) | .70 |
| AST, IU/L | 1449 (34.7) | 25 (20-32) | 3798 (23.1) | 27 (21-36) | < .0001 |
| Total cholesterol, mg/dL | 1633 (39.1) | 156 (138-178) | 1907 (11.6) | 156 (137-180) | .95 |
| HDL (mg/dL) | 1618 (38.8) | 46 (39-55) | 1837 (11.1) | 47 (39-56) | .13 |
| LDL, mg/dL | 1142 (27.4) | 87 (70-106) | 1266 (7.7) | 86 (70-104) | .42 |
| Triglycerides, mg/dL | 1633 (39.1) | 93 (67-135) | 2021 (12.3) | 91 (66-132) | .44 |
| HbA1c, % | 532 (12.8) | 5.3 (5.1, 5.5) | 959 (5.8) | 5.4 (5.2-6.7) | < .0001 |
No. represents the total number of people with a test and the percentage of cases and controls with a test performed. P values are from a Wilcoxon rank sum test and show statistically significant differences in the values between cases and controls.
Abbreviations: ALT, alanine aminotransferase; AST, aspartate aminotransferase; BMI, body mass index; BP, blood pressure; HbA1c, glycated hemoglobin A1c; HDL, high-density lipoprotein; LDL, low-density lipoprotein; TGDY, transgender and gender-diverse youth.